<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-04-01" modified="2018-01-31" version="167">
<accession>P14902</accession>
<accession>E5RGR8</accession>
<accession>F6M9T7</accession>
<accession>Q540B4</accession>
<name>I23O1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Indoleamine 2,3-dioxygenase 1</fullName>
<shortName>IDO-1</shortName>
<ecNumber evidence="11">1.13.11.52</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Indoleamine-pyrrole 2,3-dioxygenase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IDO1</name>
<name type="synonym">IDO</name>
<name type="synonym">INDO</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Biochem. Biophys. Res. Commun." volume="168" first="1" last="8">
<title>Molecular cloning, sequencing and expression of human interferon-gamma-inducible indoleamine 2,3-dioxygenase cDNA.</title>
<authorList>
<person name="Dai W."/>
<person name="Gupta S.L."/>
</authorList>
<dbReference type="PubMed" id="2109605"/>
<dbReference type="DOI" id="10.1016/0006-291X(90)91666-G"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>INDUCTION BY IFNG</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="Nucleic Acids Res." volume="18" first="367" last="367">
<title>Primary structure of human indoleamine 2,3-dioxygenase deduced from the nucleotide sequence of its cDNA.</title>
<authorList>
<person name="Tone S."/>
<person name="Takikawa O."/>
<person name="Habara-Ohkubo A."/>
<person name="Kadoya A."/>
<person name="Yoshida R."/>
<person name="Kido R."/>
</authorList>
<dbReference type="PubMed" id="2326172"/>
<dbReference type="DOI" id="10.1093/nar/18.2.367"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1992" name="Biochem. Biophys. Res. Commun." volume="189" first="530" last="536">
<title>Gene structure of human indoleamine 2,3-dioxygenase.</title>
<authorList>
<person name="Kadoya A."/>
<person name="Tone S."/>
<person name="Maeda H."/>
<person name="Minatogawa Y."/>
<person name="Kido R."/>
</authorList>
<dbReference type="PubMed" id="1449503"/>
<dbReference type="DOI" id="10.1016/0006-291X(92)91590-M"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-01" db="EMBL/GenBank/DDBJ databases">
<title>Human indoleamine 2,3-dioxygenase from peripheral blood.</title>
<authorList>
<person name="He X."/>
<person name="Xu L."/>
<person name="Liu Y."/>
<person name="Zeng Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Peripheral blood</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2011-04" db="EMBL/GenBank/DDBJ databases">
<title>Cloning and expression of human indolamine 2,3 dioxygenase.</title>
<authorList>
<person name="Qureshi A.M."/>
<person name="Asghar K."/>
<person name="Ashiq T."/>
<person name="Anwar A."/>
<person name="Raza M.I."/>
<person name="Noor F."/>
<person name="Qadri I."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1991" name="FASEB J." volume="5" first="2516" last="2522">
<title>Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.</title>
<authorList>
<person name="Taylor M.W."/>
<person name="Feng G.S."/>
</authorList>
<dbReference type="PubMed" id="1907934"/>
</citation>
<scope>REVIEW</scope>
<scope>INDUCTION BY IFNG</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Nat. Med." volume="9" first="1269" last="1274">
<title>Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.</title>
<authorList>
<person name="Uyttenhove C."/>
<person name="Pilotte L."/>
<person name="Theate I."/>
<person name="Stroobant V."/>
<person name="Colau D."/>
<person name="Parmentier N."/>
<person name="Boon T."/>
<person name="Van den Eynde B.J."/>
</authorList>
<dbReference type="PubMed" id="14502282"/>
<dbReference type="DOI" id="10.1038/nm934"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="FEBS Lett." volume="580" first="2265" last="2268">
<title>Cytochrome b(5) is a major reductant in vivo of human indoleamine 2,3-dioxygenase expressed in yeast.</title>
<authorList>
<person name="Vottero E."/>
<person name="Mitchell D.A."/>
<person name="Page M.J."/>
<person name="MacGillivray R.T."/>
<person name="Sadowski I.J."/>
<person name="Roberge M."/>
<person name="Mauk A.G."/>
</authorList>
<dbReference type="PubMed" id="16574111"/>
<dbReference type="DOI" id="10.1016/j.febslet.2006.03.034"/>
</citation>
<scope>COFACTOR</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="7082" last="7087">
<title>Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.</title>
<authorList>
<person name="Metz R."/>
<person name="Duhadaway J.B."/>
<person name="Kamasani U."/>
<person name="Laury-Kleintop L."/>
<person name="Muller A.J."/>
<person name="Prendergast G.C."/>
</authorList>
<dbReference type="PubMed" id="17671174"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-1872"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="J. Mol. Evol." volume="65" first="705" last="714">
<title>Evolution of vertebrate indoleamine 2,3-dioxygenases.</title>
<authorList>
<person name="Yuasa H.J."/>
<person name="Takubo M."/>
<person name="Takahashi A."/>
<person name="Hasegawa T."/>
<person name="Noma H."/>
<person name="Suzuki T."/>
</authorList>
<dbReference type="PubMed" id="18026683"/>
<dbReference type="DOI" id="10.1007/s00239-007-9049-1"/>
</citation>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Cancer Immunol. Immunother." volume="58" first="153" last="157">
<title>IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.</title>
<authorList>
<person name="Loeb S."/>
<person name="Koenigsrainer A."/>
<person name="Zieker D."/>
<person name="Bruecher B.L."/>
<person name="Rammensee H.G."/>
<person name="Opelz G."/>
<person name="Terness P."/>
</authorList>
<dbReference type="PubMed" id="18418598"/>
<dbReference type="DOI" id="10.1007/s00262-008-0513-6"/>
</citation>
<scope>DIFFERENCE BETWEEN IDO1 AND IDO2</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2014" name="Exp. Mol. Med." volume="46" first="E121" last="E121">
<title>Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2.</title>
<authorList>
<person name="Lee Y.K."/>
<person name="Lee H.B."/>
<person name="Shin D.M."/>
<person name="Kang M.J."/>
<person name="Yi E.C."/>
<person name="Noh S."/>
<person name="Lee J."/>
<person name="Lee C."/>
<person name="Min C.K."/>
<person name="Choi E.Y."/>
</authorList>
<dbReference type="PubMed" id="25394548"/>
<dbReference type="DOI" id="10.1038/emm.2014.69"/>
</citation>
<scope>DIFFERENCE BETWEEN IDO1 AND IDO2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2015" name="FEBS J." volume="282" first="2735" last="2745">
<title>Low efficiency IDO2 enzymes are conserved in lower vertebrates, whereas higher efficiency IDO1 enzymes are dispensable.</title>
<authorList>
<person name="Yuasa H.J."/>
<person name="Mizuno K."/>
<person name="Ball H.J."/>
</authorList>
<dbReference type="PubMed" id="25950090"/>
<dbReference type="DOI" id="10.1111/febs.13316"/>
</citation>
<scope>DIFFERENCE BETWEEN IDO1 AND IDO2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2015" name="OncoImmunology" volume="4" first="E1003012" last="E1003012">
<title>Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance.</title>
<authorList>
<person name="Vigneron N."/>
<person name="van Baren N."/>
<person name="Van den Eynde B.J."/>
</authorList>
<dbReference type="PubMed" id="26155395"/>
<dbReference type="DOI" id="10.1080/2162402X.2014.1003012"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="Trends Immunol." volume="34" first="137" last="143">
<title>Indoleamine 2,3 dioxygenase and metabolic control of immune responses.</title>
<authorList>
<person name="Munn D.H."/>
<person name="Mellor A.L."/>
</authorList>
<dbReference type="PubMed" id="23103127"/>
<dbReference type="DOI" id="10.1016/j.it.2012.10.001"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="Front. Immunol." volume="5" first="384" last="384">
<title>New insights into IDO biology in bacterial and viral infections.</title>
<authorList>
<person name="Schmidt S.V."/>
<person name="Schultze J.L."/>
</authorList>
<dbReference type="PubMed" id="25157255"/>
<dbReference type="DOI" id="10.3389/fimmu.2014.00384"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2015" name="Front. Immunol." volume="6" first="34" last="34">
<title>Tryptophan-degrading enzymes in tumoral immune resistance.</title>
<authorList>
<person name="van Baren N."/>
<person name="Van den Eynde B.J."/>
</authorList>
<dbReference type="PubMed" id="25691885"/>
<dbReference type="DOI" id="10.3389/fimmu.2015.00034"/>
</citation>
<scope>REVIEW</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2015" name="J. Med. Chem." volume="58" first="9421" last="9437">
<title>Challenges in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.</title>
<authorList>
<person name="Roehrig U.F."/>
<person name="Majjigapu S.R."/>
<person name="Vogel P."/>
<person name="Zoete V."/>
<person name="Michielin O."/>
</authorList>
<dbReference type="PubMed" id="25970480"/>
<dbReference type="DOI" id="10.1021/acs.jmedchem.5b00326"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="2611" last="2616">
<title>Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase.</title>
<authorList>
<person name="Sugimoto H."/>
<person name="Oda S."/>
<person name="Otsuki T."/>
<person name="Hino T."/>
<person name="Yoshida T."/>
<person name="Shiro Y."/>
</authorList>
<dbReference type="PubMed" id="16477023"/>
<dbReference type="DOI" id="10.1073/pnas.0508996103"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH HEME</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="ACS Med. Chem. Lett." volume="5" first="1119" last="1123">
<title>Crystal structures and structure-activity relationships of imidazothiazole derivatives as IDO1 inhibitors.</title>
<authorList>
<person name="Tojo S."/>
<person name="Kohno T."/>
<person name="Tanaka T."/>
<person name="Kamioka S."/>
<person name="Ota Y."/>
<person name="Ishii T."/>
<person name="Kamimoto K."/>
<person name="Asano S."/>
<person name="Isobe Y."/>
</authorList>
<dbReference type="PubMed" id="25313323"/>
<dbReference type="DOI" id="10.1021/ml500247w"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.79 ANGSTROMS) IN COMPLEX WITH HEME</scope>
<scope>COFACTOR</scope>
</reference>
<comment type="function">
<text evidence="8 11 21 22 23">Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway (PubMed:17671174). Involved in the peripheral immune tolerance, contributing to maintain homeostasis by preventing autoimmunity or immunopathology that would result from uncontrolled and overreacting immune responses (PubMed:25691885). Tryptophan shortage inhibits T lymphocytes division and accumulation of tryptophan catabolites induces T-cell apoptosis and differentiation of regulatory T-cells (PubMed:25691885). Acts as a suppressor of anti-tumor immunity (PubMed:23103127, PubMed:25157255, PubMed:14502282, PubMed:25691885). Limits the growth of intracellular pathogens by depriving tryptophan (PubMed:25691885). Protects the fetus from maternal immune rejection (PubMed:25691885).</text>
</comment>
<comment type="catalytic activity">
<text evidence="11">D-tryptophan + O(2) = N-formyl-D-kynurenine.</text>
</comment>
<comment type="catalytic activity">
<text evidence="11">L-tryptophan + O(2) = N-formyl-L-kynurenine.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="9 15">
<name>heme</name>
<dbReference type="ChEBI" id="CHEBI:30413"/>
</cofactor>
<text evidence="9 10 15">Binds 1 heme group per subunit (PubMed:16477023, PubMed:25313323). In the active form, the heme iron is in its ferrous state Fe(+2). The catalytic cycle does not alter the oxidation state of the heme, but IDO1 is prone to autoxidation (PubMed:16574111).</text>
</comment>
<comment type="enzyme regulation">
<text evidence="11">Activity is inhibited by and MTH-trp (methylthiohydantoin-DL-tryptophan), modestly inhibited by L-1MT (1-methyl-L-tryptophan) but not D-1MT (1-methyl-D-tryptophan).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="12">21.23 uM for L-tryptophan</KM>
<KM evidence="12">4.6 mM for D-tryptophan</KM>
<text>Catalytic efficiency for L-tryptophan is 150 times higher than for D-tryptophan.</text>
</kinetics>
</comment>
<comment type="pathway">
<text>Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2.</text>
</comment>
<comment type="subunit">
<text evidence="23">Monomer.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7 23">Cytoplasm</location>
<location evidence="7 23">cytosol</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="13 17 19">Expressed in mature dendritic cells located in lymphoid organs (including lymph nodes, spleen, tonsils, Peyers's patches, the gut lamina propria, and the thymic medulla), in some epithelial cells of the female genital tract, as well as in endothelial cells of term placenta and in lung parenchyma (PubMed:25691885). Weakly or not expressed in most normal tissues, but mostly inducible in most tissues (PubMed:25691885). Expressed in more than 50% of tumors, either by tumoral, stromal, or endothelial cells (expression in tumor is associated with a worse clinical outcome) (PubMed:18418598). Not overexpressed in tumor-draining lymph nodes (PubMed:26155395, PubMed:25691885).</text>
</comment>
<comment type="induction">
<text evidence="14 20 22">By IFNG/IFN-gamma in most cells (PubMed:2109605, PubMed:1907934). Exogenous inflammatory stimuli induce the expression of IDO1 in antigen-presenting cells such as dendritic cells, macrophages and B-cells (PubMed:25157255).</text>
</comment>
<comment type="miscellaneous">
<text evidence="24">IDO1 is the target for therapy in a range of clinical settings, including cancer, chronic infections, autoimmune and allergic syndromes, and transplantation.</text>
</comment>
<comment type="miscellaneous">
<text evidence="13 16 18">IDO1 and IDO2 are 2 distinct enzymes which catalyze the same reaction. IDO2 affinity for tryptophan is much lower than that of IDO1. 50% of Caucasians harbor polymorphisms which abolish IDO2 enzymatic activity. IDO2 is expressed in human tumors in an inactive form: tryptophan degradation is entirely provided by IDO1 in these cells (PubMed:18418598). IDO2 may play a role as a negative regulator of IDO1 by competing for heme-binding with IDO1 (PubMed:25394548). Low efficiency IDO2 enzymes have been conserved throughout vertebrate evolution, whereas higher efficiency IDO1 enzymes are dispensable in many lower vertebrate lineages (PubMed:25950090). IDO1 may have arisen by gene duplication of a more ancient proto-IDO gene before the divergence of marsupial and eutherian (placental) mammals.</text>
</comment>
<comment type="miscellaneous">
<text evidence="22">Elevated IDO1 expression is a hallmark of major viral infections including HIV, HBV, HCV or influenza and also of major bacteria infections, such as Tb, CAP, listeriosis and sepsis. Depletion of tryptophan and production of tryptophan metabolites with bactericidal activity are important as direct anti-pathogen mechanisms. Pathogens are able to highjack the immunosuppressive effects of IDO1 and make use of them to facilitate their own life cycle.</text>
</comment>
<comment type="similarity">
<text evidence="25">Belongs to the indoleamine 2,3-dioxygenase family.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL" id="AC007991"/>
</conflict>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/IDO1ID40973ch8p11.html"/>
</comment>
<dbReference type="EC" id="1.13.11.52" evidence="11"/>
<dbReference type="EMBL" id="M34455">
<property type="protein sequence ID" value="AAA36081.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X17668">
<property type="protein sequence ID" value="CAA35663.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M86472">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M86473">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M86474">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M86475">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M86476">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M86477">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M86478">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M86479">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M86480">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M86481">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="JF772862">
<property type="protein sequence ID" value="AEF30540.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY221100">
<property type="protein sequence ID" value="AAO34405.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313259">
<property type="protein sequence ID" value="BAG36069.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007991">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC027882">
<property type="protein sequence ID" value="AAH27882.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47847.1"/>
<dbReference type="PIR" id="PC1161">
<property type="entry name" value="PC1161"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002155.1">
<property type="nucleotide sequence ID" value="NM_002164.5"/>
</dbReference>
<dbReference type="UniGene" id="Hs.840"/>
<dbReference type="PDB" id="2D0T">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDB" id="2D0U">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDB" id="4PK5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDB" id="4PK6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.45"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDB" id="4U72">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDB" id="4U74">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDB" id="5EK2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDB" id="5EK3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.21"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDB" id="5EK4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDB" id="5ETW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDB" id="5WMU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=11-403"/>
</dbReference>
<dbReference type="PDB" id="5WMV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=11-403"/>
</dbReference>
<dbReference type="PDB" id="5WMW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.03"/>
<property type="chains" value="A/B=11-403"/>
</dbReference>
<dbReference type="PDB" id="5WMX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.69"/>
<property type="chains" value="A/B=11-403"/>
</dbReference>
<dbReference type="PDB" id="5WN8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=12-403"/>
</dbReference>
<dbReference type="PDB" id="5XE1">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=1-403"/>
</dbReference>
<dbReference type="PDBsum" id="2D0T"/>
<dbReference type="PDBsum" id="2D0U"/>
<dbReference type="PDBsum" id="4PK5"/>
<dbReference type="PDBsum" id="4PK6"/>
<dbReference type="PDBsum" id="4U72"/>
<dbReference type="PDBsum" id="4U74"/>
<dbReference type="PDBsum" id="5EK2"/>
<dbReference type="PDBsum" id="5EK3"/>
<dbReference type="PDBsum" id="5EK4"/>
<dbReference type="PDBsum" id="5ETW"/>
<dbReference type="PDBsum" id="5WMU"/>
<dbReference type="PDBsum" id="5WMV"/>
<dbReference type="PDBsum" id="5WMW"/>
<dbReference type="PDBsum" id="5WMX"/>
<dbReference type="PDBsum" id="5WN8"/>
<dbReference type="PDBsum" id="5XE1"/>
<dbReference type="ProteinModelPortal" id="P14902"/>
<dbReference type="SMR" id="P14902"/>
<dbReference type="BioGrid" id="109832">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="IntAct" id="P14902">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="MINT" id="MINT-1414454"/>
<dbReference type="STRING" id="9606.ENSP00000430505"/>
<dbReference type="BindingDB" id="P14902"/>
<dbReference type="ChEMBL" id="CHEMBL4685"/>
<dbReference type="DrugBank" id="DB00150">
<property type="generic name" value="L-Tryptophan"/>
</dbReference>
<dbReference type="DrugBank" id="DB01065">
<property type="generic name" value="Melatonin"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2829"/>
<dbReference type="iPTMnet" id="P14902"/>
<dbReference type="PhosphoSitePlus" id="P14902"/>
<dbReference type="BioMuta" id="IDO1"/>
<dbReference type="DMDM" id="123948"/>
<dbReference type="EPD" id="P14902"/>
<dbReference type="PaxDb" id="P14902"/>
<dbReference type="PeptideAtlas" id="P14902"/>
<dbReference type="PRIDE" id="P14902"/>
<dbReference type="DNASU" id="3620"/>
<dbReference type="Ensembl" id="ENST00000518237">
<property type="protein sequence ID" value="ENSP00000430950"/>
<property type="gene ID" value="ENSG00000131203"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000522495">
<property type="protein sequence ID" value="ENSP00000430505"/>
<property type="gene ID" value="ENSG00000131203"/>
</dbReference>
<dbReference type="GeneID" id="3620"/>
<dbReference type="KEGG" id="hsa:3620"/>
<dbReference type="UCSC" id="uc003xnm.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc064mfy.1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3620"/>
<dbReference type="DisGeNET" id="3620"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000131203.12"/>
<dbReference type="GeneCards" id="IDO1"/>
<dbReference type="HGNC" id="HGNC:6059">
<property type="gene designation" value="IDO1"/>
</dbReference>
<dbReference type="HPA" id="HPA023072"/>
<dbReference type="HPA" id="HPA023149"/>
<dbReference type="HPA" id="HPA027772"/>
<dbReference type="MIM" id="147435">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P14902"/>
<dbReference type="OpenTargets" id="ENSG00000131203"/>
<dbReference type="PharmGKB" id="PA29869"/>
<dbReference type="eggNOG" id="ENOG410IGEY">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQHE">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000002154"/>
<dbReference type="HOGENOM" id="HOG000203926"/>
<dbReference type="HOVERGEN" id="HBG006100"/>
<dbReference type="InParanoid" id="P14902"/>
<dbReference type="KO" id="K00463"/>
<dbReference type="OMA" id="NIAVPYC"/>
<dbReference type="OrthoDB" id="EOG091G0DCU"/>
<dbReference type="PhylomeDB" id="P14902"/>
<dbReference type="TreeFam" id="TF330978"/>
<dbReference type="BioCyc" id="MetaCyc:HS05502-MONOMER"/>
<dbReference type="BRENDA" id="1.13.11.11">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="1.13.11.52">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-71240">
<property type="pathway name" value="Tryptophan catabolism"/>
</dbReference>
<dbReference type="SABIO-RK" id="P14902"/>
<dbReference type="UniPathway" id="UPA00333">
<property type="reaction ID" value="UER00453"/>
</dbReference>
<dbReference type="ChiTaRS" id="IDO1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P14902"/>
<dbReference type="GeneWiki" id="Indoleamine_2,3-dioxygenase"/>
<dbReference type="GenomeRNAi" id="3620"/>
<dbReference type="PRO" id="PR:P14902"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000131203"/>
<dbReference type="ExpressionAtlas" id="P14902">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P14902">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030485">
<property type="term" value="C:smooth muscle contractile fiber"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032421">
<property type="term" value="C:stereocilium bundle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009055">
<property type="term" value="F:electron transfer activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0020037">
<property type="term" value="F:heme binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0033754">
<property type="term" value="F:indoleamine 2,3-dioxygenase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004833">
<property type="term" value="F:tryptophan 2,3-dioxygenase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002534">
<property type="term" value="P:cytokine production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007565">
<property type="term" value="P:female pregnancy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002376">
<property type="term" value="P:immune system process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0034276">
<property type="term" value="P:kynurenic acid biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033555">
<property type="term" value="P:multicellular organismal response to stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032693">
<property type="term" value="P:negative regulation of interleukin-10 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070233">
<property type="term" value="P:negative regulation of T cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042130">
<property type="term" value="P:negative regulation of T cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002678">
<property type="term" value="P:positive regulation of chronic inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032735">
<property type="term" value="P:positive regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070234">
<property type="term" value="P:positive regulation of T cell apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002666">
<property type="term" value="P:positive regulation of T cell tolerance induction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002830">
<property type="term" value="P:positive regulation of type 2 immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036269">
<property type="term" value="P:swimming behavior"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006569">
<property type="term" value="P:tryptophan catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019441">
<property type="term" value="P:tryptophan catabolic process to kynurenine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-UniPathway"/>
</dbReference>
<dbReference type="InterPro" id="IPR000898">
<property type="entry name" value="Indolamine_dOase"/>
</dbReference>
<dbReference type="InterPro" id="IPR037217">
<property type="entry name" value="Trp/Indoleamine_2_3_dOase-like"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR28657">
<property type="entry name" value="PTHR28657"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01231">
<property type="entry name" value="IDO"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF140959">
<property type="entry name" value="SSF140959"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00876">
<property type="entry name" value="IDO_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00877">
<property type="entry name" value="IDO_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0223">Dioxygenase</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0349">Heme</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0823">Tryptophan catabolism</keyword>
<feature type="chain" description="Indoleamine 2,3-dioxygenase 1" id="PRO_0000215204">
<location>
<begin position="1"/>
<end position="403"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron (heme proximal ligand)" evidence="1 2 3 4 9 15">
<location>
<position position="346"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35059413." id="VAR_053368">
<original>A</original>
<variation>T</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AEF30540." ref="5" evidence="25">
<original>G</original>
<variation>R</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="13"/>
<end position="15"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="19"/>
<end position="21"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="34"/>
<end position="36"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="37"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="46"/>
<end position="51"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="55"/>
<end position="61"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="67"/>
<end position="69"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="73"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="95"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="101"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="105"/>
<end position="118"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="126"/>
<end position="129"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="135"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="145"/>
<end position="147"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="148"/>
<end position="151"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="160"/>
<end position="178"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="181"/>
<end position="189"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="193"/>
<end position="214"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="217"/>
<end position="220"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="223"/>
<end position="228"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="230"/>
<end position="233"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="237"/>
<end position="239"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="241"/>
<end position="243"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="247"/>
<end position="249"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="250"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="254"/>
<end position="257"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="264"/>
<end position="266"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="268"/>
<end position="276"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="287"/>
<end position="295"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="296"/>
<end position="298"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="301"/>
<end position="311"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="316"/>
<end position="321"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="322"/>
<end position="324"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="326"/>
<end position="353"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="355"/>
<end position="360"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="381"/>
<end position="397"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2D0T"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2D0U"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4PK5"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4PK6"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4U72"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EK3"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P28776"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14502282"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16477023"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16574111"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17671174"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18026683"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18418598"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2109605"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25313323"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25394548"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25691885"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25950090"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26155395"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1907934"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="23103127"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25157255"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25691885"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25970480"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<sequence length="403" mass="45326" checksum="E92CF57AD0D0BA8D" modified="1990-04-01" version="1">
MAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVE
KLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLEL
PPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKV
IPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGN
PQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMP
PAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQ
QPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>